Sort
326,823 grants matching “clinical trial”
Cardiovascular CT Clinical Research
$1,542,715Marcus Chen · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Early in vivo Expressed Antigens and their Role in Virulence, Immune Response, and Vaccines for Coccidioidomycosis
$1,542,693Paul Stephen Keim · Northern Arizona University · U19 · FY2023 · AI
Ancillary Studies of NAFLD and NASH in HIV infected Adults
$1,542,615Naga P. Chalasani · Indiana University Indianapolis · R01 · FY2023 · DK
Brain Vascular Malformation Consortium: Predictor's of Clinical Course
$1,542,523Helen Kim · University Of California, San Francisco · U54 · FY2021 · NS
Influenza vaccination using a microneedle patch
$1,542,519Mark R Prausnitz · Georgia Institute Of Technology · U01 · FY2010 · EB
PRIMAVO: Interactive exploration of cancer patient precision immune monitoring data in clinical trials
$1,542,450Zeynep Hulya Gumus · Icahn School Of Medicine At Mount Sinai · R33 · FY2021 · CA
Addressing Key Social-Structural Risk Factors for Racial Disparities in Maternal Morbidity in Southeastern Wisconsin (ASCEND WI)
$1,542,406Anna Palatnik · Medical College Of Wisconsin · U54 · FY2024 · HD
Ex Vivo Female Reproductive Tract Integration In a 3D Microphysiologic System
$1,542,237Teresa K Woodruff · Northwestern University At Chicago · UH3 · FY2015 · TR
Non-opiate topical formulations for treating pain associated with molar extractions
$1,542,183Alan Parr · Arcato Laboratories, Inc. · R44 · FY2021 · DE
Redefining Chiari Type I Malformation and its Impact on Brain Development
$1,542,174Chenyang Lu · Washington University · P01 · FY2025 · NS
Open Health Natural Language Processing Collaboratory
$1,542,081Hongfang Liu · Mayo Clinic Rochester · U01 · FY2018 · TR
Confirmatory Safety and Efficacy Trial of Magnetic Seizure Therapy for Depression
$1,542,062Zafiris J. Daskalakis · Centre For Addiction And Mental Health · R01 · FY2017 · MH
Preclinical Development of LIGO-069-136, An Anti-Inflammatory Pulmonary Therapeut
$1,541,966Robert Frost Bargatze · Takeda Vaccines, Inc. · R44 · FY2006 · AI
NIAMS: CORT
$1,541,891Robert A Lafyatis · Boston University Medical Campus · P50 · FY2013 · AR
Environmental influences on fertility and reproductive health
$1,541,761Anne Marie Jukic · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Nonmyeloablative allogeneic PBSC in globin disorders
$1,541,591John Tisdale · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Pediatric Oncology Branch Behavioral Science Core
$1,541,507John Glod · Division Of Basic Sciences - Nci · ZID · FY2025 · CA
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2022 · HD
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2021 · HD
Novel Therapeutics for FSHD
$1,541,442Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · P50 · FY2020 · HD
Probing Tumor Microenvironment Using Nanotechnology
$1,541,419Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2011 · CA
Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis
$1,541,209William E. Carson · Ohio State University · UM1 · FY2019 · CA
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
$1,541,147Kevin O Saunders · Duke University · U19 · FY2025 · AI
Administrative Core
$1,541,147Kevin O Saunders · Duke University · U19 · FY2025 · AI
Project 2. cGMP manufacture of HIV-1 Env trimer sortase A-conjugated nanoparticles
$1,541,146Jason Dickens · Duke University · U19 · FY2025 · AI